In Quantitative imaging in medicine and surgery
BACKGROUND : Predicting the mutation status of the epidermal growth factor receptor (EGFR) gene based on an integrated positron emission tomography/computed tomography (PET/CT) image of non-small cell lung cancer (NSCLC) is a noninvasive, low-cost method which is valuable for targeted therapy. Although deep learning has been very successful in robotic vision, it is still challenging to predict gene mutations in PET/CT-derived studies because of the small amount of medical data and the different parameters of PET/CT devices.
METHODS : We used the advanced EfficientNet-V2 model to predict the EGFR mutation based on fused PET/CT images. First, we extracted 3-dimensional (3D) pulmonary nodules from PET and CT as regions of interest (ROIs). We then fused each single PET and CT image. The network model was used to predict the mutation status of lung nodules by the new data after fusion, and the model was weighted adaptively. The EfficientNet-V2 model used multiple channels to represent nodules comprehensively.
RESULTS : We trained the EfficientNet-V2 model through our PET/CT fusion algorithm using a dataset of 150 patients. The prediction accuracy of EGFR and non-EGFR mutations was 86.25% in the training dataset, and the accuracy rate was 81.92% in the validation set.
CONCLUSIONS : Combined with experiments, the demonstrated PET/CT fusion algorithm outperformed radiomics methods in predicting EGFR and non-EGFR mutations in NSCLC.
Xiao Zhenghui, Cai Haihua, Wang Yue, Cui Ruixue, Huo Li, Lee Elaine Yuen-Phin, Liang Ying, Li Xiaomeng, Hu Zhanli, Chen Long, Zhang Na
2023-Mar-01
EfficientNet-V2 Model, epidermal growth factor receptor (EGFR), positron emission tomography/computed tomography (PET/CT)
